|
Index of reports
> Cases with Respiratory Distress (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cancidas (Caspofungin) where reactions include respiratory distress. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Cancidas side effects in 15 year old female
Reported by a individual with unspecified qualification from Ireland on 2012-08-06
Patient: 15 year old female
Reactions: Nephropathy Toxic, Drug Interaction, Multiple Drug Overdose, Respiratory Distress, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cancidas
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-05-30
Cyclosporine
Dosage: 200 mg; ;po
Administration route: Oral
Indication: Aplasia
Start date: 2012-04-23
End date: 2012-05-31
Gentamicin
Dosage: 170 ug; ;iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-26
End date: 2012-05-30
Ticarcillin Disodium / Clavulanate Potassium (Claventin / 00973701 / )
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-28
End date: 2012-06-01
Trimethoprim + Sulfamethoxazole
Dosage: ; tid; iv
Indication: Prophylaxis
Start date: 2012-04-01
Vancomycin
Dosage: 2 gm; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-22
Voriconazole
Dosage: ; iv
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Atgam; Ciprofloxacin; Filgrastim
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Hepatic Failure, Drug Interaction, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciprofloxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26
Patient: female
Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-25
End date: 2012-04-27
Atgam
Dosage: 40 mg/kg, unk
Start date: 2012-04-23
Bactrim
Dosage: 1 df, qw3
Indication: Prophylaxis
Start date: 2012-04-01
Cancidas
Start date: 2012-05-28
End date: 2012-05-30
Ciproflaxacin
Start date: 2012-05-28
End date: 2012-06-06
Clavulanate Potassium
Dosage: 1 df, tid
Start date: 2012-05-28
End date: 2012-06-01
Clavulanate Potassium
Dosage: unk
Start date: 2012-06-04
Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
Neoral
Dosage: 1 df, bid
Administration route: Oral
Start date: 2012-04-23
Vancomycin
Dosage: 1 g, bid
Start date: 2012-05-22
Vancomycin
Dosage: 2250 mg, unk
Start date: 2012-05-31
Vancomycin
Dosage: 1800 mg, unk
Start date: 2012-06-06
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-06-04
Vancomycin
Dosage: 2000 mg, unk
Start date: 2012-05-25
Vfend
Administration route: Oral
Vfend
Dosage: 1 df, bid
Indication: Bronchopulmonary Aspergillosis
Start date: 2012-05-14
End date: 2012-05-31
Other drugs received by patient: Colistin; Neupogen
Possible Cancidas side effects in 14 year old male
Reported by a physician from Spain on 2012-06-04
Patient: 14 year old male
Reactions: Respiratory Disorder, Anaphylactic Reaction, Subcutaneous Emphysema, Acidosis, Pyrexia, Transaminases Increased, Weight Increased, Cardio-Respiratory Arrest, Hepatotoxicity, Simplex Virus Test Positive, Decubitus Ulcer, Graft Versus Host Disease in Skin, Pneumothorax, Intracranial Pressure Increased, Escherichia Sepsis, Bone Marrow Transplant, Clostridium Test Positive, Hypotension, Complications of Bone Marrow Transplant, Respiratory Distress, Aplasia, Renal Failure, Fungal Test Positive, Hypoproteinaemia, Bradycardia, Staphylococcus Test Positive
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Dosage: iv
Indication: Aspergillosis
Start date: 2010-12-01
End date: 2011-03-01
Cancidas
Dosage: iv
Indication: Rhinitis
Start date: 2010-12-01
End date: 2011-03-01
Voriconazole
Dosage: iv
Indication: Prophylaxis
Other drugs received by patient: Cyclophosphamide; Amphotericin B (+) Cholesterol (+) Diste
Possible Cancidas side effects in 14 year old male
Reported by a physician from Spain on 2012-05-30
Patient: 14 year old male
Reactions: Respiratory Disorder, Graft Versus Host Disease, Subcutaneous Emphysema, Pyrexia, Acidosis, Transaminases Increased, Weight Increased, Cardio-Respiratory Arrest, Hepatotoxicity, Decubitus Ulcer, Simplex Virus Test Positive, Pneumothorax, Intracranial Pressure Increased, Escherichia Sepsis, Clostridium Test Positive, Hypotension, Aplasia, Respiratory Distress, Renal Failure, Hypoproteinaemia, Bradycardia, Staphylococcus Test Positive
Adverse event resulted in: death
Drug(s) suspected as cause:
Cancidas
Dosage: iv
Indication: Rhinitis
Start date: 2010-12-01
End date: 2011-03-01
Cancidas
Dosage: iv
Indication: Aspergillosis
Start date: 2010-12-01
End date: 2011-03-01
Voriconazole
Dosage: iv
Indication: Prophylaxis
Other drugs received by patient: Amphotericin B (+) Cholesterol (+) Diste; Cyclophosphamide
|
